Related Experiment Video
Updated: Aug 6, 2026
05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal
Nobuhide Kobori1, Guy L Clifton, Pramod K Dash
1Vivian L. Smith Center for Neurological Research, Department of Neurobiology and Anatomy, University of Texas Medical School at Houston, 77225, USA.
Journal of Neurotrauma
|July 27, 2006
Summary
Traumatic brain injury (TBI) increases catecholamine synthesis in the prefrontal cortex, potentially explaining working memory deficits. This finding offers new insights for treating cognitive impairments after brain injury.
Area of Science:
- Neuroscience
- Neurobiology
- Traumatic Brain Injury Research
Background:
- Traumatic brain injury (TBI) often leads to cognitive deficits, particularly in working memory (WM), linked to prefrontal cortex (PFC) dysfunction.
- The precise cellular and molecular mechanisms behind WM dysfunction post-TBI remain unclear.
- Catecholamine neurotransmission in the medial prefrontal cortex (mPFC) is crucial for normal WM function.
Purpose of the Study:
- To investigate the role of catecholamine biosynthesis in WM deficits following TBI.
- To measure changes in tyrosine hydroxylase (TH) activity and catecholamine levels in the mPFC after TBI.
Main Methods:
- Utilized the cortical impact injury model to induce TBI in rodents, known to cause WM deficits.
- Measured protein levels and activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis.
- Quantified dopamine (DA) and norepinephrine (NE) levels in microdissected prelimbic/infralimbic (PL/IL) cortices.
Main Results:
- TBI significantly increased TH protein levels and activity in the PL/IL regions.
- Tissue dopamine (DA) and norepinephrine (NE) levels were elevated in the PL/IL following TBI.
- These findings indicate enhanced catecholamine biosynthesis in the mPFC after TBI.
Conclusions:
- Altered catecholamine signaling in the mPFC may contribute to cognitive impairments, including WM dysfunction, after TBI.
- The observed increase in catecholamine synthesis warrants further investigation into its role in TBI-induced prefrontal dysfunction.
- These results may inform therapeutic strategies aimed at mitigating cognitive deficits in brain injury patients.
Related Concept Videos
01:14Role of Cerebellum and Prefrontal Cortex in Memory
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...